madman
Super Moderator
Sue Goldstein presented the latest advances in female sexual dysfunctions. She talked about current pharmacologic treatment for sexual desire and presented the ISSWSH guide on how to use testosterone in women in a safe way. In the domain of arousal, Sue Goldstein talked about the efforts of ISSWSH to suggest a different name for persistent genital arousal syndrome and the significance of such a change. She also talked about the characteristics of this problem, contributing factors, treatment goals, and algorithms. This lecture is part of a special IOSS event titled “Scientific Advances in Sexual Medicine’ dedicated to our colleague and friend Ariel Gustavo Scafuri MD, PhD, FACS, FECSM. Ariel was a board-certified urologist and obstetrician-gynecologist and a full Professor of Anatomy at the Federal University of Ceará, Medical School, Ceará, Brazil and unfortunately passed away due to complications from COVID-19. Ariel was one of few that had received gynecology, urology, and psychology comprehensive training, thus being equipped to provide true multidisciplinary care to his patients. Ariel was also actively involved in the major national and international scientific societies: the International Society of Sexual Medicine (ISSM), the European Society of Sexual Medicine (ESSM), the International Society for the Study of Women’s Sexual Health (ISSWSH), the Latin American Society of Sexual Medicine (SLAMS) and also the Brazilian Association of Sexual Medicine (ABEMSS). We will always remember him as a loving man. May his passion for learning and his enthusiasm for scientific novelty influence the next generations of sexual medicine specialists.
Summary
Advances in Female Sexual Dysfunctions were discussed during the presentation. The International Society for the Study of Women's Sexual Health (ISSWSH) focuses on providing accurate scientific information to researchers, healthcare providers, and the public. One significant advance is the development of guidelines for using testosterone in women to treat low sexual desire safely and effectively. Another area of focus is persistent genital arousal disorder (PGAD), which has been renamed "genital pelvic dysesthesia" (GPD) to address the distressing symptoms experienced by patients. The presentation highlighted the complexity of PGAD and the need for a multidimensional approach to diagnosis and treatment.Highlights
- ISSWSH is committed to advancing the field of women's sexual health through scientific research and education.
- Guidelines for the safe and effective use of testosterone in women have been developed.
- Persistent genital arousal disorder (PGAD) has been renamed "genital pelvic dysesthesia" (GPD) to better reflect the condition and reduce stigma.
- PGAD is a complex disorder with triggers in multiple regions, requiring a comprehensive approach to diagnosis and treatment.
- Testosterone guidelines for women's sexual desire
- Renaming of persistent genital arousal disorder to genital pelvic dysesthesia
- Multidimensional approach to diagnosing and treating PGAD
Last edited by a moderator:
